CClinicalTrials.gg
Not yet recruitingNCT06432270Updated May 29, 2024

Effect of Diabetes Mellitus on Cardiac Autonomic Function in Surgical Patients Undergoing General Anesthesia

An observational study in Diabetic Autonomic Neuropathy Type 2, Perioperative Complication and Temperature Change, Body, sponsored by Zhujiang Hospital. Not yet recruiting. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-29.

Sponsored by Zhujiang Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
388
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Because autonomic neuropathy affects the constriction of thermoregulatory blood vessels, it is more difficult for diabetic patients to maintain their own body temperature in cold environments than normal people, and therefore it is more difficult for diabetic patients to maintain a relatively constant body temperature regardless of the temperature of the environment than normal people. So are diabetic patients under general anesthesia more susceptible to intraoperative hypothermia? How does heart rate variability change in diabetic patients under general anesthesia? If diabetic patients are more susceptible to intraoperative hypothermia under general anesthesia, is this related to their cardiac autonomic dysfunction?

Read the detailed description

According to the latest version of data released by the International Diabetes Federation (IDF) in 2021, it can be seen that the number of people with diabetes globally or in China is high and the percentage is increasing.In 2021, there are 537 million people with diabetes globally, and there are about 141 million in China, which is an increase of about 21.55% compared with 2019 . Perioperative hypothermia is a clinical phenomenon in which a patient's core body temperature is below 36°C for non-medical purposes during the perioperative period, with an incidence of about 7-90%, which can lead to a variety of adverse outcomes.In hot environments, sweating and vasodilation are severely compromised in diabetic patients due to autonomic neuropathy, which prevents the body from transferring heat from the inside of the body to the skin through vasodilation, increased blood flow, and sweating. Similarly, because autonomic neuropathy affects the constriction of thermoregulatory blood vessels, it is more difficult for diabetic patients to maintain their own body temperature in cold environments than normal people, and therefore it is more difficult for diabetic patients to maintain a relatively constant body temperature regardless of the temperature of the environment than normal people. On the other hand, general anesthesia and external environmental factors in the operating room increase the incidence of intraoperative hypothermia, and theoretically, diabetic patients are more prone to dramatic fluctuations in their own body temperature during surgery, making it difficult for them to adapt to changes in the external environment. Due to the complex pathophysiological mechanism of diabetes, which affects multiple systems throughout the body, there are currently more than 100 complications of diabetes, of which autonomic neuropathy has the most serious impact on diabetic patients. Cardiac autonomic neuropathy is one of the most common and serious complications of diabetic autonomic neuropathy, with a prevalence of 63% . And heart rate variability is one of the most common tests for diabetic cardiac autonomic dysfunction. So are diabetic patients under general anesthesia more susceptible to intraoperative hypothermia? How does heart rate variability change in diabetic patients under general anesthesia? If diabetic patients are more susceptible to intraoperative hypothermia under general anesthesia, is this related to their cardiac autonomic dysfunction? However, there are still no studies and little attention has been paid to it.

02

Conditions studied

  • Diabetic Autonomic Neuropathy Type 2
  • Perioperative Complication
  • Temperature Change, Body

Keywords

  • diabetes
  • general anesthesia
  • Cardiac autonomic dysfunction
  • perioperative temperature
03

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

This study is expected to collect patients who are hospitalized in Zhujiang Hospital of Southern Medical University and are proposed to undergo surgery

Inclusion criteria

  • 18 years old ≤ age ≤ 80 years old, gender is not limited;
  • BMI index of 18-35 kg/m2 (including 18 kg/m2 and 35 kg/m2 );
  • Diagnosed with diabetes mellitus;
  • ASA Ⅰ - Ⅱ;
  • Elective laparoscopic abdominal surgery under general anesthesia;
  • Operating time >2 hours and \<6 hours;
  • Voluntary participation and signing of an informed consent form;
  • Ability to be followed up in a timely manner.

Exclusion criteria

Exclusion Criteria:

  • Abnormally elevated preoperative inflammatory indicators;
  • Core body temperature ≥37.5 degrees Celsius;
  • Patients with previous clear central nervous system disease, history of psychiatric disorders, or epilepsy;
  • Patients with verbal communication or hearing or visual impairment, who were unable to communicate well and had poor compliance;
  • Intraoperative use of vasodilator (uradil, sodium nitroprusside, nitroglycerin);
  • Any high-risk subjects with complete atrioventricular block or complete atrioventricular conduction tissue without implanted pacemakers, multiple premature ventricular beats, single premature ventricular beats (heart rate \<45 beats/min), heart failure in NYHA (New York Heart Association) class III or higher;
  • Subjects with any other clinically significant 12-lead electrocardiogram (ECG) or echocardiogram abnormality at the time of screening, ejection fraction (EF) \<40%, or any other significant abnormality in the opinion of the investigator;
  • Subjects deemed by the investigator to be unfit for this clinical trial for any other reason (anesthesia assessment unfit for surgery or preanesthetic hypertension).

Withdrawal Criteria:

  • Serious adverse events, abnormal laboratory tests, or other conditions that indicate no further benefit or increased risk to the subject's safety from continued participation in the study;
  • Incomplete recording of critical data (temperature or heart rate variability);
  • Unstable condition requiring further admission to the intensive care unit;
  • Intraoperative use of dexmedetomidine; 5. Perioperative nerve block.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
388 participants (estimated)
Target follow-up
3 Days
Patient registry
Yes

Groups and cohorts

  • diabetic group

    Patients with a diagnosis of diabetes mellitus who are about to undergo general anesthesia who are expected to undergo laparoscopic surgery

  • Non-diabetic group

    Nondiabetic patients anticipating laparoscopic surgery who are about to undergo general anesthesia

05

What researchers measure

Primary outcomes

  1. Changes in perioperative core body temperature in diabetic patients

    The study was conducted by using a perioperative core body temperature monitoring system to continuously monitor and record core body temperature data for 12 hours preoperatively - intraoperatively - 12 hours postoperatively, and then calculating the mean core body temperature per minute at 12 hours preoperatively, intraoperatively, and 12 hours postoperatively, respectively, to compare whether diabetic patients had lower mean core body temperature per minute intraoperatively than non-diabetic patients, and whether diabetic patients had a decrease in intraoperative body temperature compared to 12 hours preoperatively and 12 hours postoperatively. Mean intraoperative core body temperature per minute (°C/min) = Mean intraoperative core body temperature/operating time.

    Time frame: 12 hours before surgery,during operation,12 hours after surgery

Secondary outcomes

  1. time to onset of temperature drop

    observing the time period during which diabetic and non-diabetic patients began to drop below the mean temperature at 12 hours preoperatively and comparing how early or late the temperature began to drop in both groups

    Time frame: Baseline and 12 hours before surgery,0-30 minutes after induction ,30-60 minutes after induction,60-90 minutes after induction,90-120 minutes after induction,120-150 minutes after induction,150-180 minutes after induction,12 hours after surgery

  2. time to temperature drop to nadir

    Observing the period of time during which diabetic and non-diabetic patients experienced a drop in temperature to nadir, and comparing how fast or slow the temperature dropped to the lowest point

    Time frame: Baseline and 12 hours before surgery,0-30 minutes after induction ,30-60 minutes after induction,60-90 minutes after induction,90-120 minutes after induction,120-150 minutes after induction,150-180 minutes after induction,12 hours after surgery

  3. The magnitude of body temperature decline

    Comparing whether the average core body temperature of diabetic patients was lower than that of non-diabetic patients at each time period after induction.

    Time frame: Baseline and 12 hours before surgery,0-30 minutes after induction ,30-60 minutes after induction,60-90 minutes after induction,90-120 minutes after induction,120-150 minutes after induction,150-180 minutes after induction,12 hours after surgery

  4. Changes in heart rate variability (HRV)

    using 24-hour Holter ECG to collect HRV data from 12 hours before surgery to induction (first administration of medication), and from the time the patients left the recovery room to 12 hours after surgery, and observing the changes in HRV data of the patients of the two groups in the two time periods

    Time frame: 12 hours before surgery,12 hours after surgery

Other outcomes

  1. Age

    Age of the participants(years)

    Time frame: the preoperative visit period

  2. Height

    Height of the participants(meters)

    Time frame: the preoperative visit period

  3. BMI

    BMI of the participants(kg/m2)

    Time frame: the preoperative visit period

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06432270
Lead sponsor
Zhujiang Hospital
Responsible party
Sponsor
First posted
May 29, 2024
Start date
Jun 1, 2024 (estimated)
Primary completion
May 1, 2025 (estimated)
Completion
Jun 1, 2025 (estimated)
Last update
May 29, 2024

Study contacts

Xinying Wang, Master
Contact
597436551@qq.com
86-13539410563
Zhujiang Hospital of Southern Medical University
study chair · Southern Medical University, China

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion